industry pr

Press release news from the public relations clients of Tiziani Whitmyre, Inc.

Posts Tagged ‘cellular resolution image’


Wednesday, September 5th, 2007

Lucid Appoints Dr. Clifford Perlis as U.S. Medical Director

ROCHESTER, NEW YORK, USA – September 5, 2007Lucid, Inc., a leading U.S. cellular imaging and technology company, today announced the appointment of Clifford Perlis, M.D., M.Be., as the new U.S. Medical Director. He is currently the Director of Mohs Surgery in the Department of Medical Oncology at Fox Chase Cancer Center in Philadelphia.

In the newly created position at Lucid, Dr. Perlis will play a key role in the direction of Lucid’s clinical and medical research programs, support medical training and marketing initiatives, and aid in the submission of IRB protocols to third party organizations.

Dr. Perlis received his M.D. degree from the University of Pennsylvania School of Medicine in Philadelphia, and also holds a Masters in Bioethics from the University of Pennsylvania.

“Lucid is an innovative and dynamic company with a broad technology portfolio in the medical imaging and information fields. The company plans to initially apply these innovative imaging technologies in the field of dermatology, allowing my peers to attain a level of diagnostic capability similar to that radiologists routinely achieve using MRI and CT scans of the body. Ultimately, Lucid’s confocal imaging technology will be applied in numerous other medical technologies,” said Dr. Perlis.

Lucid is the creator of the non-invasive VivaScope® confocal microscope that provides cellular resolution images of skin, and of the VivaNet™, an Internet-based, DICOM-compliant medical information system that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

“As Lucid moves toward the launch of its clinical applications for VivaScopes and the VivaNet, it is important to have a voice on our management team that can express the needs of physicians and patients to our Board of Directors and the company’s outside stakeholders. Dr. Clifford Perlis, a practicing dermatologic surgeon with degrees in medicine and bioethics is very well suited to this role. I look forward to working with Dr. Perlis as we move Lucid’s unique technologies into routine medical practice around the world.” said Jay Eastman, Chairman and CEO of Lucid, Inc.

About Lucid Inc.
Lucid Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNet(TM) system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com or call +1-585-239-9800.

# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us

Technorati tags: , , , , , , , , , , , , , , ,


Thursday, August 2nd, 2007

Lucid to Showcase VivaNetTM Telemedicine Server for Dermatology Applications at AAD Summer Academy Meeting

ROCHESTER, NEW YORK – August 1, 2007 – Lucid, Inc. (http://www.lucid-tech.com/) will showcase its VivaNetTM telemedicine server for dermatology applications at the American Academy of Dermatology’s (AAD) Summer Academy Meeting, August 1-5, 2007.

The VivaNetTM server is intended to link dermatology practitioners using Lucid’s non-invasive VivaScope® confocal imagers with other dermatologists or pathologists via the Internet.

Lucid’s non-invasive VivaScope® confocal microscopes provide cellular resolution images of skin that may be used by a dermatologist to assist in forming a clinical judgment for a variety of skin conditions. The VivaNetTM is an Internet-based, DICOM compliant application that is intended to provide fast, accurate, and secure storage, retrieval and transfer of VivaScope® digital cellular resolution images across the Internet to facilitate professional collaboration and consultation.

During a typical VivaScope® session, both dermatoscopic quality, full color macroscopic pictures and microscopic, cellular resolution images of the patient’s skin are imaged. Once all of the images from a single session are completed, the images and patient related data are transferred for storage to the secure VivaNetTM server and are immediately available for retrieval by and transfer to other authorized practitioners for their review and collaboration.

For more information or to see a live demo of the new VivaNet™ or VivaScope® technology, visit Lucid at the AAD Summer Academy Meeting, in booth #414 in the Hilton New York, August 1-5, 2007. Or, visit Lucid online at http://www.lucid-tech.com/ or by phone 585-239-9800.

Lucid Inc., based in Rochester, New York, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. The Company’s digital VivaNetTM server, coupled with its ability to image in-vivo (living) tissue is envisioned to ultimately aid medical practitioners and pathologists in screening for skin cancer and other dermatologic conditions with clarity, speed and patient comfort. For more information, visit http://www.lucid-tech.com/.

# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us

Technorati tags: , , , , , , , , , , , , , , ,


Wednesday, February 21st, 2007

Lucid Previews VivaNet(TM) Telemedicine Server For Dermatology Applications

WASHINGTON, D.C., USA — February 21, 2007 — Lucid, Inc. previewed its VivaNetTM telemedicine server for dermatology applications.

The VivaNet(TM) server is intended to link dermatology practitioners using Lucid’s non-invasive VivaScope® confocal imagers with other dermatologists or pathologists via the Internet.

“Lucid’s non-invasive VivaScope® confocal microscopes provide cellular resolution images of skin that may be used by a dermatologist to assist in forming a clinical judgment for a variety of skin conditions,” said Jay Eastman, Chairman and CEO of Lucid, Inc. He continued, “VivaNet(TM) is intended to provide fast, accurate, and secure storage, retrieval and transfer of VivaScope® digital cellular resolution images across the Internet to facilitate professional collaboration and consultation.”

During a typical VivaScope® imaging session, both dermatoscopic quality, full color macroscopic pictures and microscopic, cellular resolution images of the patient’s skin are imaged. Once all of the images for a single session are completed, the images and patient related data are transferred for storage to the secure VivaNet(TM) server and are immediately available for retrieval by and transfer to other authorized practitioners for their review and collaboration.

VivaNet(TM) is an Internet-based, DICOM-compliant application that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images. DICOM, which is an acronym for Digital Imaging and Communications in Medicine, is an internationally accepted, and widely used open standard for the storage, retrieval and transfer of medical images. HIPAA-compliance, privacy, and data integrity are assured by using proven DICOM compliant software modules that incorporate advanced encryption techniques.

“Our plan is that VivaNet(TM) will ultimately make in-vivo confocal images available for review by other dermatologists and pathologists in minutes, not days, thus enabling rapid, real-time professional collaboration,” said Eastman. “Lucid’s ultimate goal is that practitioners will rapidly receive a pathologic interpretation of confocal images from a VivaScope® session, potentially assisting the practitioner in arriving at a clinical judgment while the patient is still in the doctor’s office.”

Under a 3-year grant from the National Institute of Health’s National Cancer Institute, Lucid is conducting a five site clinical study to determine the diagnostic accuracy of VivaScope® images for pigmented lesions. Pilot studies of the procedure, published in 2004 – 2006, demonstrated high sensitivity and specificity for VivaScope images when read by a panel of diagnostic readers with relatively little training in confocal image interpretation (30 to 60 minutes). This study will be facilitated by the use of the VivaNet(TM) server.

“We are excited to introduce VivaNet(TM) to the dermatology community and believe that the combination of Lucid’s patented VivaScope® and VivaNet(TM) technologies, that enable near real-time storage, retrieval and communication of in-vivo confocal images, will ultimately bring these tools into routine clinical use,” said Eastman.

About Lucid, Inc.
Lucid Inc., based in Rochester, New York, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. The Company’s digital VivaNet(TM) server, coupled with its ability to image in-vivo (living) tissue is envisioned to ultimately aid medical practitioners and pathologists in screening for skin cancer and other dermatologic conditions with clarity, speed and patient comfort. For more information, visit http://www.lucid-tech.com/.

# # #

Press release contact: Tiziani Whitmyre, www.tizinc.com


Industry PR is proudly powered by WordPress.
WordPress